Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

Researchers found that pairing the antibiotic rifampicin with a second compound turned multidrug resistance into a weakness—providing proof of concept for using basic science to design life-saving ...

A radical strategy to tackle drug-resistant tuberculosis could involve reprogramming the metabolism of immune cells called macrophages. This approach makes the bacteria they harbour more sensitive to ...

A new study in Nature Medicine estimates 2 million people are incorrectly told they have TB each year — and 1 million ...

Cutting edge research at IISc, Bengaluru, is expected to arm India’s fight against TB as it still carries one of the world’s largest disease burdens.